21 USC 355e - Pharmaceutical security

(a)

In general

(b)

Standards development

(1)

In general

(2)

Standardized numeral identifier

(3)

Promising technologies

The standards developed under this subsection shall address promising technologies, which may include—

(A)

radio frequency identification technology;

(B)

nanotechnology;

(C)

encryption technologies; and

(D)

other track-and-trace or authentication technologies.

(4)

Interagency collaboration

In carrying out this subsection, the Secretary shall consult with Federal health and security agencies, including—

(A)

the Department of Justice;

(B)

the Department of Homeland Security;

(C)

the Department of Commerce; and

(D)

other appropriate Federal and State agencies.

(c)

Inspection and enforcement

(1)

In general

(2)

Activities

(d)

Definition

(June 25, 1938, ch. 675, § 505D, as added Pub. L. 110–85, title IX, § 913, Sept. 27, 2007, 121 Stat. 952.)